封面
市场调查报告书
商品编码
1975259

全球脑氧饱和度监测市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Cerebral Oximetry Monitoring Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计脑氧饱和度监测市场将从 2025 年的 2.6651 亿美元成长到 2034 年的 5.1655 亿美元,2026 年至 2034 年的复合年增长率为 7.63%。

由于人们越来越意识到在手术和重症监护期间监测脑部健康的重要性,全球脑氧饱和度监测市场正稳定成长。这些设备测量脑部氧饱和度,有助于预防神经系统併发症。心血管疾病和神经系统疾病的日益普遍推动了对先进监测系统的需求。不断扩大的医疗基础设施和非侵入性监测解决方案的技术进步也为全球市场的成长提供了支持。

主要成长要素包括手术数量的增加,尤其是心血管手术和新生儿手术。医院越来越多地采用脑氧饱和度监测系统来提高病患安全性和手术效果。包括携带式和无线监测设备在内的技术创新正在加速这些系统的应用。此外,随着全球人口老化,需要高阶围手术全期监测的慢性疾病发生率也在增加。

未来,与数位健康平台和即时数据分析的整合有望提高临床决策的准确性。新兴国家医疗保健服务的普及将创造新的成长机会。感测器精度和小型化的持续提升将促进其进一步应用。随着病患安全标准的日益严格,脑氧饱和度监测预计仍将是先进医疗保健系统的重要组成部分。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章:全球脑氧饱和度监测市场:依应用领域划分

  • 市场分析、洞察与预测
  • 心臟外科手术
  • 血管外科
  • 其他的

第五章:全球脑氧饱和度监测市场:依年龄组别划分

  • 市场分析、洞察与预测
  • 儿童
  • 成人

第六章:全球脑氧饱和度监测市场:依最终用途划分

  • 市场分析、洞察与预测
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第七章 全球脑氧饱和度监测市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 亚太其他地区
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Masimo Corporation
    • Medtronic Plc
    • Edwards Lifesciences Corporation
    • Nonin Medical Inc
    • ISS Inc
    • Hamamatsu Photonics KK
    • Mespere LifeSciences Inc
    • GE HealthCare
    • Terumo Cardiovascular Systems Corporation
    • Philips Healthcare
简介目录
Product Code: VMR112112198

The Cerebral Oximetry Monitoring Market size is expected to reach USD 516.55 Million in 2034 from USD 266.51 Million (2025) growing at a CAGR of 7.63% during 2026-2034.

The Global Cerebral Oximetry Monitoring Market is growing steadily due to rising awareness of brain health monitoring during surgeries and critical care procedures. These devices measure oxygen saturation in the brain, helping prevent neurological complications. Increasing prevalence of cardiovascular and neurological disorders has boosted demand for advanced monitoring systems. Expanding healthcare infrastructure and technological advancements in non-invasive monitoring solutions are supporting global market growth.

Key drivers include the growing number of surgical procedures, particularly cardiac and neonatal surgeries. Hospitals are increasingly adopting cerebral oximetry systems to enhance patient safety and improve surgical outcomes. Technological innovation, including portable and wireless monitoring devices, is making these systems more accessible. Additionally, aging populations worldwide are increasing the incidence of chronic conditions requiring advanced perioperative monitoring.

In the future, integration with digital health platforms and real-time data analytics will enhance clinical decision-making. Expanding healthcare access in emerging economies will create new growth opportunities. Continuous improvements in sensor accuracy and miniaturization will further drive adoption. As patient safety standards become more stringent, cerebral oximetry monitoring is expected to remain a critical component of advanced medical care systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Cardiac Surgery
  • Vascular Surgery
  • Others

By Age Group

  • Pediatric
  • Adult

By End Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Masimo Corporation, Medtronic plc, Edwards Lifesciences Corporation, Nonin Medical Inc, ISS Inc, Hamamatsu Photonics KK, Mespere LifeSciences Inc, GE HealthCare, Terumo Cardiovascular Systems Corporation, Philips Healthcare
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Cardiac Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Vascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY AGE GROUP 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Age Group
  • 5.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Application
    • 7.2.2 By Age Group
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Application
    • 7.3.2 By Age Group
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Application
    • 7.4.2 By Age Group
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Application
    • 7.5.2 By Age Group
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Application
    • 7.6.2 By Age Group
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CEREBRAL OXIMETRY MONITORING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Masimo Corporation
    • 9.2.2 Medtronic Plc
    • 9.2.3 Edwards Lifesciences Corporation
    • 9.2.4 Nonin Medical Inc
    • 9.2.5 ISS Inc
    • 9.2.6 Hamamatsu Photonics K.K
    • 9.2.7 Mespere LifeSciences Inc
    • 9.2.8 GE HealthCare
    • 9.2.9 Terumo Cardiovascular Systems Corporation
    • 9.2.10 Philips Healthcare